Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Catrullo

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Allergy|September 23, 1997
Specific conjunctival challenge in polysensitized subjectsG Ciprandi, A Catrullo, A Ballestrero, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 1995
Loratadine in the treatment of cough associated with allergic rhinoconjunctivitisG Ciprandi, S Buscaglia, A Catrullo, et al.
Allergy|June 24, 1998
Loratadine reduces the expression of ICAM-1G Ciprandi, A Catrullo, P Cerqueti, et al.
Journal of Investigational Allergology & Clinical Immunology|April 23, 1999
Azelastine eye drops reduce conjunctival hyperresponsiveness to hyperosmolar glucose challenge in children with asymptomatic mite conjunctivitisG Ciprandi, A Catrullo, M Tosca, et al.
Journal of Investigational Allergology & Clinical Immunology|November 1, 1993
Nedocromil sodium and the immune responseG Ciprandi, S Buscaglia, M Albano, et al.
Allergy|December 1, 1996
Antiallergic activity of topical lodoxamide on in vivo and in vitro modelsG Ciprandi, S Buscaglia, A Catrullo, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 1997
Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activityG Ciprandi, S Buscaglia, A Catrullo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Isolation and in vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: functional and molecular characterisation for their use in adoptive immunotherapyG Melioli, G Ratto, M Guastella, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 1, 1996
Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitroS Buscaglia, F Paolieri, A Catrullo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Allergy|September 23, 1997
Specific conjunctival challenge in polysensitized subjectsG Ciprandi, A Catrullo, A Ballestrero, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 1995
Loratadine in the treatment of cough associated with allergic rhinoconjunctivitisG Ciprandi, S Buscaglia, A Catrullo, et al.
Allergy|June 24, 1998
Loratadine reduces the expression of ICAM-1G Ciprandi, A Catrullo, P Cerqueti, et al.
Journal of Investigational Allergology & Clinical Immunology|April 23, 1999
Azelastine eye drops reduce conjunctival hyperresponsiveness to hyperosmolar glucose challenge in children with asymptomatic mite conjunctivitisG Ciprandi, A Catrullo, M Tosca, et al.
Journal of Investigational Allergology & Clinical Immunology|November 1, 1993
Nedocromil sodium and the immune responseG Ciprandi, S Buscaglia, M Albano, et al.
Allergy|December 1, 1996
Antiallergic activity of topical lodoxamide on in vivo and in vitro modelsG Ciprandi, S Buscaglia, A Catrullo, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 1997
Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activityG Ciprandi, S Buscaglia, A Catrullo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Isolation and in vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: functional and molecular characterisation for their use in adoptive immunotherapyG Melioli, G Ratto, M Guastella, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 1, 1996
Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitroS Buscaglia, F Paolieri, A Catrullo, et al.
Pageof 1